Chartarlactam A is a novel compound with anti-hyperlipidemic activity. Chartarlactam A exhibits inhibitory potential in HepG2 cells.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Research Areas > Metabolic Disease
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.